JP2017511329A5 - - Google Patents

Download PDF

Info

Publication number
JP2017511329A5
JP2017511329A5 JP2016560389A JP2016560389A JP2017511329A5 JP 2017511329 A5 JP2017511329 A5 JP 2017511329A5 JP 2016560389 A JP2016560389 A JP 2016560389A JP 2016560389 A JP2016560389 A JP 2016560389A JP 2017511329 A5 JP2017511329 A5 JP 2017511329A5
Authority
JP
Japan
Prior art keywords
oxy
amine
dimethylpentan
methyl
difluoromethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016560389A
Other languages
English (en)
Japanese (ja)
Other versions
JP6411541B2 (ja
JP2017511329A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/023805 external-priority patent/WO2015153720A1/en
Publication of JP2017511329A publication Critical patent/JP2017511329A/ja
Publication of JP2017511329A5 publication Critical patent/JP2017511329A5/ja
Application granted granted Critical
Publication of JP6411541B2 publication Critical patent/JP6411541B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016560389A 2014-04-02 2015-04-01 ビアリールキナーゼ阻害剤 Active JP6411541B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201461973942P 2014-04-02 2014-04-02
US61/973,942 2014-04-02
US201462061591P 2014-10-08 2014-10-08
US62/061,591 2014-10-08
PCT/US2015/023805 WO2015153720A1 (en) 2014-04-02 2015-04-01 Biaryl kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2017511329A JP2017511329A (ja) 2017-04-20
JP2017511329A5 true JP2017511329A5 (enExample) 2018-03-15
JP6411541B2 JP6411541B2 (ja) 2018-10-24

Family

ID=52988448

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016560389A Active JP6411541B2 (ja) 2014-04-02 2015-04-01 ビアリールキナーゼ阻害剤

Country Status (27)

Country Link
US (7) US9902722B2 (enExample)
EP (1) EP3126351B1 (enExample)
JP (1) JP6411541B2 (enExample)
KR (1) KR102379518B1 (enExample)
CN (1) CN106458994B (enExample)
AU (1) AU2015240869B2 (enExample)
BR (1) BR112016022298B1 (enExample)
CA (1) CA2944466C (enExample)
CL (1) CL2016002502A1 (enExample)
CY (1) CY1120988T1 (enExample)
DK (1) DK3126351T3 (enExample)
EA (1) EA028942B1 (enExample)
ES (1) ES2700549T3 (enExample)
HR (1) HRP20181899T1 (enExample)
HU (1) HUE041457T2 (enExample)
IL (1) IL248086B (enExample)
LT (1) LT3126351T (enExample)
MX (1) MX2016012829A (enExample)
PE (1) PE20170004A1 (enExample)
PL (1) PL3126351T3 (enExample)
PT (1) PT3126351T (enExample)
RS (1) RS58062B1 (enExample)
SG (1) SG11201608195QA (enExample)
SI (1) SI3126351T1 (enExample)
SM (1) SMT201800665T1 (enExample)
WO (1) WO2015153720A1 (enExample)
ZA (1) ZA201606767B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10253027B2 (en) 2013-07-08 2019-04-09 Bristol-Myers Squibb Company Aryl lactam kinase inhibitors
WO2015054358A1 (en) 2013-10-11 2015-04-16 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
CN106488915B (zh) 2014-02-13 2020-10-02 因赛特公司 作为lsd1抑制剂的环丙胺
SG10201806849WA (en) 2014-02-13 2018-09-27 Incyte Corp Cyclopropylamines as lsd1 inhibitors
US9527835B2 (en) 2014-02-13 2016-12-27 Incyte Corporation Cyclopropylamines as LSD1 inhibitors
EA028942B1 (ru) * 2014-04-02 2018-01-31 Бристол-Майерс Сквибб Компани Биарильные ингибиторы киназы
US9695167B2 (en) 2014-07-10 2017-07-04 Incyte Corporation Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors
US9695168B2 (en) 2014-07-10 2017-07-04 Incyte Corporation Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors
TW201613925A (en) 2014-07-10 2016-04-16 Incyte Corp Imidazopyrazines as LSD1 inhibitors
US9944647B2 (en) 2015-04-03 2018-04-17 Incyte Corporation Heterocyclic compounds as LSD1 inhibitors
EP3292124B1 (en) * 2015-04-10 2019-05-22 Bristol-Myers Squibb Company 6h-isochromeno[3,4-c]pyridines and benzo[c][1,7]naphthyridin-6-(5h)-ones as adaptor associated kinase 1 (aak1) inhibitors
UA126277C2 (uk) 2015-08-12 2022-09-14 Інсайт Корпорейшн Солі інгібітору lsd1
WO2017059080A1 (en) * 2015-10-01 2017-04-06 Bristol-Myers Squibb Company Biaryl kinase inhibitors
WO2017059085A1 (en) * 2015-10-01 2017-04-06 Bristol-Myers Squibb Company Biaryl kinase inhibitors
JP7190906B2 (ja) 2017-01-24 2022-12-16 住友化学株式会社 縮合複素環化合物及びそれを含有する組成物
US10968200B2 (en) 2018-08-31 2021-04-06 Incyte Corporation Salts of an LSD1 inhibitor and processes for preparing the same
TW202120495A (zh) * 2019-08-02 2021-06-01 美商愛彼特生物製藥股份有限公司 經取代環丙基—2,2'—聯嘧啶基化合物、其類似物及其使用方法
EP4138844A1 (en) 2020-04-21 2023-03-01 Lexicon Pharmaceuticals, Inc. 4-(3-(pyridin-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl)piperazine for use in the the treatment of cov-229e or cov-oc43 coronaviruses infections
US11730723B2 (en) 2020-04-21 2023-08-22 Lexicon Pharmaceuticals, Inc. Compounds and methods for treating viral infections
TW202210462A (zh) * 2020-05-28 2022-03-16 中國大陸商杭州中美華東製藥有限公司 (s)-2-胺基-3-(4-(2,3-二甲基吡啶-4-基)苯基丙酸甲酯及其鹽的製備方法
EP4159719A4 (en) * 2020-05-28 2024-07-17 Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. Preparation method for (s)-2-amino-3-(4-(2,3-dimethylpyridin-4-yl)phenyl)methyl propionate diacid salt
TW202317532A (zh) * 2021-07-15 2023-05-01 大陸商四川海思科製藥有限公司 Aak1抑制劑及其用途
CN115872927A (zh) * 2021-09-30 2023-03-31 武汉人福创新药物研发中心有限公司 Aak1抑制剂及其用途
US12312325B2 (en) * 2022-03-01 2025-05-27 Lexicon Pharmaceuticals, Inc. Methods and compounds useful in the synthesis of an AAK1 inhibitor
AU2023229156A1 (en) * 2022-03-01 2024-08-15 Lexicon Pharmaceuticals, Inc. Solid forms of (s)-l-((2',6-bis(difluoromethyl)-[2,4'-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine and salts thereof
CA3246512A1 (en) 2022-03-23 2023-09-28 Assia Chemical Industries Ltd. SOLID FORMS OF LX9211 AND THEIR SALTS
JP2025538197A (ja) * 2022-11-10 2025-11-26 シーザン ハイスーク ファーマシューティカル カンパニー リミテッド Aak1阻害剤を含有する医薬組成物
WO2024125668A1 (zh) * 2022-12-13 2024-06-20 上海海雁医药科技有限公司 杂环取代的五并六元杂芳基衍生物、其药物组合物及应用与制备方法
CN120641406A (zh) * 2023-01-16 2025-09-12 上海海雁医药科技有限公司 杂环取代的含氮杂环衍生物、其药物组合物及应用与制备方法
AU2024253688A1 (en) 2023-04-07 2025-10-23 Alicorn Pharmaceutical Co., Ltd. Nitrogen-containing heterocyclic compound as aak1 inhibitor
CN118772152B (zh) * 2023-04-07 2026-01-02 艾立康药业股份有限公司 作为aak1抑制剂的氮杂环类化合物
WO2025092928A1 (zh) * 2023-11-02 2025-05-08 西藏海思科制药有限公司 一种可抑制连接蛋白相关激酶1的化合物、制备及其用途

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
AU2515992A (en) 1991-08-20 1993-03-16 Genpharm International, Inc. Gene targeting in animal cells using isogenic dna constructs
US20030187026A1 (en) * 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
WO2004041810A1 (en) * 2002-11-05 2004-05-21 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of jak and other protein kinases
US20070185152A1 (en) * 2004-03-02 2007-08-09 Smithkline Beecham Corporation Inhibitors of akt activity
MX2008013203A (es) * 2006-04-12 2008-10-22 Wyeth Corp Analogos de anilino-pirimidina fenilo y benzotiofeno.
CA2677096A1 (en) * 2007-01-31 2008-08-07 Vertex Pharmaceuticals Incorporated Kinase inhibitors
WO2013134336A2 (en) * 2012-03-09 2013-09-12 Lexicon Pharmaceuticals, Inc. Inhibition of adaptor associated kinase 1 for the treatment of pain
US8703953B2 (en) * 2012-03-09 2014-04-22 Bristol-Myers Squibb Company Aryl ether-base kinase inhibitors
US8901305B2 (en) * 2012-07-31 2014-12-02 Bristol-Myers Squibb Company Aryl lactam kinase inhibitors
EP2958924B1 (en) 2013-02-22 2016-12-28 Bristol-Myers Squibb Company 5h-chromeno[3,4-c]pyridines as inhibitors of adaptor associated kinase 1 (aak1)
US10253027B2 (en) 2013-07-08 2019-04-09 Bristol-Myers Squibb Company Aryl lactam kinase inhibitors
MX2016002924A (es) 2013-09-11 2016-06-06 Squibb Bristol Myers Co Inhibidores de cinasa a base de eter arilico.
CA2937529A1 (en) 2014-01-29 2015-08-06 Bristol-Myers Squibb Company Aryl lactam kinase inhibitors
EA201691397A1 (ru) 2014-01-31 2016-11-30 Бристол-Майерс Сквибб Компани Хинолиновые ингибиторы киназы
EA028942B1 (ru) 2014-04-02 2018-01-31 Бристол-Майерс Сквибб Компани Биарильные ингибиторы киназы
EP3200797A1 (en) 2014-09-30 2017-08-09 Bristol-Myers Squibb Company Quinazoline-based kinase inhibitors
EP3292124B1 (en) 2015-04-10 2019-05-22 Bristol-Myers Squibb Company 6h-isochromeno[3,4-c]pyridines and benzo[c][1,7]naphthyridin-6-(5h)-ones as adaptor associated kinase 1 (aak1) inhibitors
WO2017059080A1 (en) 2015-10-01 2017-04-06 Bristol-Myers Squibb Company Biaryl kinase inhibitors
WO2017059085A1 (en) 2015-10-01 2017-04-06 Bristol-Myers Squibb Company Biaryl kinase inhibitors
US10981190B2 (en) 2018-07-06 2021-04-20 Liqui-Box Corporation Dispensing probe for dispensing flowable material

Similar Documents

Publication Publication Date Title
JP2017511329A5 (enExample)
JP2018537408A5 (enExample)
NZ609955A (en) Sgc stimulators
ES2675760T3 (es) Compuestos terapéuticamente activos y métodos de uso de los mismos
JP5367707B2 (ja) Dhodh阻害剤としてのアザビフェニルアミノ安息香酸誘導体
JP2016523977A5 (enExample)
JP2016525076A5 (enExample)
NZ604004A (en) Pyridone and aza-pyridone compounds and methods of use
RU2015100942A (ru) Производное пиперидинилпиразолпиридина
RU2018138050A (ru) Производные тиазолопиридина как агонисты gpr119
JP2016525075A5 (enExample)
US10376510B2 (en) 2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer
HRP20212000T1 (hr) Aminotriazolopiridini kao inhibitori kinaze
JP2020502111A5 (enExample)
JP2015172062A5 (enExample)
JP2015503571A5 (enExample)
HRP20180546T1 (hr) Supstituirani benzilindazoli za uporabu kao inhibitori bub1 kinaze za liječenje hiperproliferativnih bolesti
JP2017530962A5 (enExample)
JP2011503230A5 (enExample)
RU2014124953A (ru) Производные аминопиридина в качестве модуляторов богатой лейцином повторной киназы 2 (lrrk2)
JP2016522232A5 (enExample)
JP2012525395A5 (enExample)
RU2019121871A (ru) Новые производные фенилпропионовой кислоты и их применение
CA2624602A1 (en) Process for preparing 6-substituted-7-azaindoles
JP2017523214A5 (enExample)